Skip to content

Author

H. Schrezenmeier

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Intrathecal mesenchymal stem cell therapy in progressive multiple sclerosis: integrated blood and CSF profiling in the SMART-MS randomized trial

It is suggested that intrathecal MSC exposure in progressive MS is associated with compartmentalized CSF proteomic changes rather than broad systemic immune alterations, demonstrating the value of integrated blood–CSF profiling for dissecting treatment-associated biology in CNS-targeted interventional trials.

D. Kleftogiannis, Sonia Gavasso, L. E. Eidem et al. · 0 citations
#protein folding Open access Sep 2026

Novel KIR2DS4:HLA-B*35 interaction predicts HLA-B*35 positive patient survival post hematopoietic stem cell transplant.

The identified novel KIR2DS4:HLA-B*35 interaction axis predicts patient survival, in both haplo-identical and fully matched, HCT and highlights that the current understanding of the KIR:HLA interactome is incomplete and requires remapping for enhanced therapeutic applications.

S. Gottschalk, Ying Li, S. Selukar et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.